- $15.90bn
- $18.34bn
- $3.90bn
- 96
- 31
- 73
- 75
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 18.96 | ||
PEG Ratio (f) | 0.62 | ||
EPS Growth (f) | 44.46% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.96 | ||
Price to Tang. Book | 6.13 | ||
Price to Free Cashflow | 41.33 | ||
Price to Sales | 4.05 | ||
EV to EBITDA | 16.61 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.55% | ||
Return on Equity | 5.25% | ||
Operating Margin | 18.7% |
Financial Summary
Year End 31st Oct | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 2,430.9 | 2,922.5 | 3,308.4 | 3,593.2 | 3,895.4 | 4,117.08 | 4,387.15 | 7.98% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -43.67 | +1022.42 | -85.99 | -21.11 | +19.52 | +103.62 | +11.14 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Directors
- Robert Weiss NEC (75)
- Albert White PRE (52)
- Brian Andrews CFO (43)
- Holly Sheffield CEX (51)
- Gerard Warner CEX (57)
- Daniel McBride COO (57)
- Agostino Ricupati SVF (55)
- Mark Drury VPR (46)
- William Kozy LED (70)
- Colleen Jay IND (59)
- Jody Lindell IND (70)
- Teresa Madden IND (65)
- Gary Petersmeyer IND (74)
- Maria Rivas IND (58)
- Last Annual
- October 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- March 4th, 1980
- Public Since
- January 21st, 1983
- No. of Shareholders
- 133
- No. of Employees
- 16,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 199,981,183

- Address
- 6101 Bollinger Canyon Road, Suite 500, SAN RAMON, 94583
- Web
- https://www.coopercos.com/
- Phone
- +1 9254603600
- Contact
- Kim Duncan
- Auditors
- KPMG LLP
Upcoming Events for COO
Q2 2025 Cooper Companies Inc Earnings Call
Q3 2025 Cooper Companies Inc Earnings Release
Similar to COO
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 20:03 UTC, shares in Cooper Companies are trading at $79.51. This share price information is delayed by 15 minutes.
Shares in Cooper Companies last closed at $79.51 and the price had moved by -11.52% over the past 365 days. In terms of relative price strength the Cooper Companies share price has underperformed the S&P500 Index by -16.8% over the past year.
The overall consensus recommendation for Cooper Companies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreCooper Companies does not currently pay a dividend.
Cooper Companies does not currently pay a dividend.
Cooper Companies does not currently pay a dividend.
To buy shares in Cooper Companies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $79.51, shares in Cooper Companies had a market capitalisation of $15.90bn.
Here are the trading details for Cooper Companies:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: COO
Based on an overall assessment of its quality, value and momentum Cooper Companies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cooper Companies is $106.63. That is 34.11% above the last closing price of $79.51.
Analysts covering Cooper Companies currently have a consensus Earnings Per Share (EPS) forecast of $3.99 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cooper Companies. Over the past six months, its share price has underperformed the S&P500 Index by -18.61%.
As of the last closing price of $79.51, shares in Cooper Companies were trading -16.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cooper Companies PE ratio based on its reported earnings over the past 12 months is 18.96. The shares last closed at $79.51.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cooper Companies' management team is headed by:
- Robert Weiss - NEC
- Albert White - PRE
- Brian Andrews - CFO
- Holly Sheffield - CEX
- Gerard Warner - CEX
- Daniel McBride - COO
- Agostino Ricupati - SVF
- Mark Drury - VPR
- William Kozy - LED
- Colleen Jay - IND
- Jody Lindell - IND
- Teresa Madden - IND
- Gary Petersmeyer - IND
- Maria Rivas - IND